Abiopharma

🔍 HARRIS CASSANDRA (Executive)

Company: ESTABLISHMENT LABS HOLDINGS INC. (ESTA)

Report Date: 2026-03-09

Detailed Transactions and Holdings:

• Acquired 7,372 shares of Common Shares (Direct)
  Date: 2026-03-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 7,372.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 12,877 shares of Stock Option (Right to buy) at $74.6 per share (Derivative)
  Date: 2026-03-09 | Code: A | Expires: 2036-02-16 | Exercise: 2027-03-09 | equity_swap_involved: 0 | shares_owned_after: 12,877.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents an award of stock units under the Issuer's 2018 Equity Incentive Plan. One-fourth of the shares subject to the award shall vest on March 9, 2027 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through such date.
• F2: One-fourth of the shares subject to the option shall vest on March 9, 2027 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.